Sorry, you need to enable JavaScript to visit this website.

Compleat logo

List of Publications (Updated 03/10/2026)
Listed in Reverse Chronology by Product Line

Publications funded by Nestlé Health Science U.S.

COMPLEAT® ORIGINAL

Compleat® Pediatric Original 1.0

  • Minor GJ, Blackmer A.  Nutritionally complete tube-feeding formula with real food ingredients – tolerance and growth outcomes in ex-premature medically complex children. J Parenter Enteral Nutr. 2026; 50: S71-S332.

  • Minor G, Yamamoto S, Cekola P, Cohen SS, Huhmann MB, Araujo Torres K. Meeting nutritional needs of the enterally-fed child with neurological impairment. J Clin Nutr Dietet. 2020;6(4):3. 

Compleat® Pediatric Original Reduced Calorie 0.6

  • Kluge A, Huhmann MB, Brannan DK. The effect of a low calorie, nutrient dense formula on the use of modular nutrition supplements in children with developmental disabilities. J Pediatr Gastroenterol Nutr. 2013:57;E89.

 

COMPLEAT® ORGANIC BLENDS

Compleat® Pediatric Organic Blends

  • Bennett K, Desai A, Henrikson A, Cekola P, Liu J, Kumar P, Klosterbuer A, Araujo Torres K. Healthcare Resource Utilization and Cost Implications of Commercial Blenderized versus Plant-Based Standard Enteral Formulas in Children and Adults in Post-Acute Care: A Retrospective Study. Clinicoecon Outcomes Res. 2025 Nov 12;17:821-833.

  • Henrikson A, Desai A, Allen F, Yuddula S, Araujo Torres K. Chronic Conditions in Children Receiving Commercially Blenderized Tube Feeding Formula in the Post-Acute Care Setting: Real World Evidence of Clinical and Health Economic Outcomes.  J Parenter Enteral Nutr.2023;47(S2):S218.

  • Henrikson A, Desai A, Allen F, Li O, Yeddula S, Araujo Torres K. Real-World Evidence on Clinical and Health Economic Outcomes among Pediatric Patients in Post-Acute Care Receiving Commercial Blenderized Tube Feeding Formulas.  J Parenter Enteral Nutr. 2022;46(S1):S214.

  • Desai A, Henrikson H, Allen F, et al. Clinical Benefits of Real Food Tube Feeding Formulas Compared to Standard Tube Feeding Formulas in Post-Acute Care Pediatric Patients. J Pediatr Gastroenterol Nutr. 2022;75(S1):S293.

  • Desai A, Henrikson A, Allen F, et al. Health Economic Benefits of Real Food Tube Feeding Formulas Compared to Standard Tube Feeding Formulas in Post-Acute Pediatric Patients. J Pediatr Gastroenterol Nutr. 2022;75(S1):S292.

  • Henrikson A, Desai A, Allen F, et al. Cost Savings Associated with Commercial Blenderized Tube Feeding Formulas in Post-Acute Care Pediatric Patients. J Pediatr Gastroenterol Nutr. 2022;75(S1):S3.

  • Adams RL.  Evaluating growth and tolerance of blenderized tube feeding formulas.  Journal of Food and Nutritional Sciences. 2021;3(1):18-33.

Compleat® Organic Blends

  • Bennett K, Desai A, Henrikson A, Cekola P, Liu J, Kumar P, Klosterbuer A, Araujo Torres K. Healthcare Resource Utilization and Cost Implications of Commercial Blenderized versus Plant-Based Standard Enteral Formulas in Children and Adults in Post-Acute Care: A Retrospective Study. Clinicoecon Outcomes Res. 2025 Nov 12;17:821-833.

  • Henrikson A, Desai A, Allen F, Yeddula S, Araujo Torres, K. Clinical Benefits of Real Food Tube Feeding Formulas Compared to  Plant-Based Standard Tube Feeding Formulas  in Post-Acute Adult Patients. J Parenter Enteral Nutr. 2023;47(S2):S102.

  • Desai A, Henrikson A, Allen F, Yeddula S, Araujo Torres K.  Main Diagnoses in Tube-Fed Adults in the Post-Acute Care Setting: Clinical and Health Economic Benefits Associated with the Use of Commercial Blenderized Enteral Nutrition Formula. J Parenter Enteral Nutr. 2023;47(S2):104.

  • Henrikson A, Desai A,  Allen F, Li, O, Yeddula S, Araujo Torres K. Real-World Evidence on Clinical and Health Economic Outcomes among Adult Patients in Post-Acute Care Receiving Commercial Blenderized Tube Feeding Formulas.  J Parenter Enteral Nutr. 2022;46(S1):S162.

  • Desai A, Henrikson A, Allen F, Kumar P, Samhitha VS, Araujo Torres K. Health Economic Benefits of Real Food Tube Feeding Formulas Compared to Standard Tube Feeding Formulas in Post-Acute Adult Patients. Presented at 44th ESPEN Congress on Clinical Nutrition and Metabolism, September 4, 2022, Vienna, Austria.

  • Henrikson A, Desai A, Allen F, Li O, Yeddula S, Araujo Torres K.  Cost Savings Associated with Commercial Blenderized Tube Feeding Formulas in Post-Acute Care Adult Patients. Presented at 44th ESPEN Congress on Clinical Nutrition and Metabolism, September 4, 2022, Vienna, Austria.

  • Steel C, Li O, Yeddula S, Hopkins B. Commercial Blenderized Tube Feeding Formula: Real-World Data on Use and Tolerance among Adult Patients in the Community. J Parenter Enteral Nutr. 2022;46:S74-S226. DOI: 10.1002/jpen.2345.

 

COMPLEAT® PEPTIDE

  • Blackmer A, Huhmann MB, Klosterbuer A. Differences in osmolality reporting for enteral formulas and implications for clinical interpretation. J Parenter Enteral Nutr. 2026;50: S71-S332.

Compleat® Pediatric Peptide 1.5

  • Minor, G., Cekola, P., Desai, A., Kumar, P., Mondal, S., Kadam, Y. V., … Klosterbuer, A. (2025). Reductions in Gastrointestinal Intolerance, Healthcare Resource Utilization and Cost Associated with a Plant-Based Peptide Enteral Formula with Fruit and Vegetable Ingredients: Retrospective Analysis of Children and Adults in Post-Acute Care. Nutrition and Dietary Supplements, 17, 63–72.

  • Desai A, Cekola P, Blackmer A, et al.  Healthcare Resource Utilization and Costs Associated with a Peptide-Based Enteral Formula with Fruit and Vegetable Ingredients: Retrospective Analysis of Children and Adults in Post-Acute Care.  Value in Health, Volume 27, Issue 6, S1(June 2024).

  • Cekola P, Desai A, Kumar P et al. Gastrointestinal Tolerance of a Peptide-Based Enteral Formula with Fruit and Vegetable Ingredients: Retrospective Analysis of Children in Post-Acute Care.  J Pediatr Gastroenterol Nutr. 2023;77(1):S551-552.

Compleat® Peptide 1.5

  • Minor, G., Cekola, P., Desai, A., Kumar, P., Mondal, S., Kadam, Y. V., … Klosterbuer, A. (2025). Reductions in Gastrointestinal Intolerance, Healthcare Resource Utilization and Cost Associated with a Plant-Based Peptide Enteral Formula with Fruit and Vegetable Ingredients: Retrospective Analysis of Children and Adults in Post-Acute Care. Nutrition and Dietary Supplements, 17, 63–72.

  • Desai A, Cekola P, Blackmer A, et al.  Healthcare Resource Utilization and Costs Associated with a Peptide-Based Enteral Formula with Fruit and Vegetable Ingredients: Retrospective Analysis of Children and Adults in Post-Acute Care.  Value in Health, Volume 27, Issue 6, S1(June 2024).

  • Cekola P, Desai A, Kumar P et al. Enhance Gastrointestinal Tolerance in Post-Acute Care Adults Receiving a Plant-Based Peptide Enteral Formula: A Retrospective Analysis. J Parenter Enteral Nutr. 2024;48:S114-116.

 

OTHER PUBLICATIONS

  • Evans J, Salvia A, Burgos RM, Mucarzel F, Saduera S. A multicenter study evaluating the gastrointestinal tolerance and acceptability of a novel high-energy, high-protein, plant-based enteral tube feed for adults. Clinical Nutrition Open Science. 2026; 65:100624.

  • Ogundere S, Carter A, Filson A, et al.  A multi-center, single arm study to evaluate the gastrointestinal tolerance and compliance of a high energy adult enteral tube feed with food derived ingredients.  Appl. Physiol. Nutr. Metab. 49: S1–S79 | dx.doi.org/10.1139/apnm-2024-009.

  • van der Linde M, Flood T, Gilson A, et al.  A multi-centre, single arm study designed to evaluate the gastro-intestinal tolerance and compliance of a standard adult enteral tube feed with food derived ingredients.  Appl. Physiol. Nutr. Metab. 49: S1–S79 | dx.doi.org/10.1139/apnm-2024-009.

  • O’Connor G, Camacho A, Saduera S.  Dietetic practice to implement a food-based enteral formula at a specialist children’s hospital in the United Kingdom: a retrospective study.  J Parenter Enteral Nutr. 2024;48:S73-S225.

  • O’Connor G, Sun Y, Gardiner B, et al.  A prospective pilot study to monitor the impact of high fiber ‘enteral formula with food-derived ingredients’ on fecal short-chain fatty acid concentrations in children admitted to intensive care with sepsis. EC Nutrition 2023;18.4: 17-27.

  • O’Connor G, Watson M, Van Der Linde M, et al.  Monitor gastrointestinal tolerance in children who have switched to an ‘enteral formula with food derived ingredients’: a national, multicenter retrospective chart review (RICIMIX study).  Nutr Clin Prac. 2022;37:929-934.

  • Samela K, Mokha, Emerick K, Davidovics ZH. Transition to a tube feeding formula with real food ingredients in pediatric patients with intestinal failure. Nutr Clin Pract. 2017;32(2): 277-281.

    All trademarks are owned by Société des Produits Nestlé S.A., Vevey, Switzerland. ©2026 Nestlé.  (Updated: 03/2026)